Renaissance Technologies’s Qualigen Therapeutics QLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,303
| Closed | -$11.2K | – | 3811 |
|
|
2024
Q2 | $11.2K | Buy |
1,303
+444
| +52% | +$3.83K | ﹤0.01% | 3416 |
|
|
2024
Q1 | $17K | Buy |
+859
| New | +$17K | ﹤0.01% | 3601 |
|
|
2022
Q4 | – | Sell |
-29
| Closed | -$4K | – | 4341 |
|
|
2022
Q3 | $4K | Buy |
+29
| New | +$4K | ﹤0.01% | 3973 |
|
|
2022
Q2 | – | Sell |
-228
| Closed | -$75K | – | 4505 |
|
|
2022
Q1 | $75K | Buy |
+228
| New | +$75K | ﹤0.01% | 3844 |
|
|
2021
Q3 | – | Sell |
-228
| Closed | -$227K | – | 3770 |
|
|
2021
Q2 | $227K | Buy |
+228
| New | +$227K | ﹤0.01% | 3222 |
|
|
2020
Q1 | – | Sell |
-26
| Closed | -$55K | – | 3724 |
|
|
2019
Q4 | $55K | Sell |
26
-1
| -4% | -$2.12K | ﹤0.01% | 3381 |
|
|
2019
Q3 | $105K | Buy |
27
+9
| +50% | +$35K | ﹤0.01% | 3257 |
|
|
2019
Q2 | $238K | Buy |
18
+8
| +80% | +$106K | ﹤0.01% | 3260 |
|
|
2019
Q1 | $112K | Buy |
10
+7
| +233% | +$78.4K | ﹤0.01% | 3289 |
|
|
2018
Q4 | $21K | Hold |
3
| – | – | ﹤0.01% | 3324 |
|
|
2018
Q3 | $68K | Hold |
3
| – | – | ﹤0.01% | 3265 |
|
|
2018
Q2 | $89K | Buy |
3
+2
| +200% | +$59.3K | ﹤0.01% | 3158 |
|
|
2018
Q1 | $27K | Buy |
+1
| New | +$27K | ﹤0.01% | 3326 |
|